10 hasil
Menampilkan 1–10 · 0,24 detik · RSS
Journal of the European Academy of Dermatology and Venereology
Scopus
ISSN 0926-9959 · Wiley · 10 artikel di indeks
-
Artikel Jurnal Teks lengkap
European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy
The evidence- and consensus-based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development Manual. Four consensus conferences were held between December 2020 and July 2021. Twenty-nine experts (including clinicians and patient…
-
Artikel Jurnal Teks lengkap
Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology ( EADV )
BACKGROUND: Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. This disease typically affects the elderly and presents with itch and localized or, most frequently, generalized bullous lesions. A subset of patients only develops…
-
Artikel Jurnal Teks lengkap
European guideline ( EuroGuiDerm ) on atopic eczema – part II : non‐systemic treatments and treatment recommendations for special AE patient populations
The evidence- and consensus-based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development Manual. Four consensus conferences were held between December 2020 and July 2021. Twenty-nine experts (including clinicians and patient…
-
Artikel Jurnal Teks lengkap
ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children
Atopic dermatitis (AD) is a highly pruritic, chronic inflammatory skin disease. The diagnosis is made using evaluated clinical criteria. Disease activity and burden are best measured with a composite score, assessing both objective and subjective symptoms, such as SCORing Atopic Dermatitis…
-
Artikel Jurnal Teks lengkap
Vascular skin symptoms in COVID‐19: a French observational study
Coronavirus 19 (COVID-19) was declared as a pandemic viral infection by the World Health Organization on 11 March 2020. Usual clinical manifestations of COVID-19 infection include fever, fatigue, myalgia, headache, diarrhoea, dry cough and dyspnoea that may lead to acute respiratory distress…
-
Artikel Jurnal Teks lengkap
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
BACKGROUND: Pemphigus encompasses a group of life-threatening autoimmune bullous diseases characterized by blisters and erosions of the mucous membranes and skin. Before the era of immunosuppressive treatment, pemphigus was almost always fatal. Due to its rarity, only few randomized controlled…
-
Artikel Jurnal Teks lengkap
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations
This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement Development Manual. The first part of the guideline includes general information on the scope and purpose, health questions covered, target…
-
Artikel Jurnal Teks lengkap
Cutaneous manifestations in COVID‐19: a new contribution
We have read with great interest Dr Recalcati's review about skin manifestations in COVID-19 as it is the first report on this subject. In a recent review on clinical characteristics of coronavirus disease 2019 in China, rash was observed in 0.2% of cases. 2 However, from the trained eyes of a…
-
Artikel Jurnal Teks lengkap
Chilblain‐like lesions during COVID‐19 epidemic: a preliminary study on 63 patients
-
Artikel Jurnal Teks lengkap
Urticarial eruption in COVID‐19 infection
Coronavirus disease (COVID-19) is spreading quickly across the world, until a pandemic condition was announced by the WHO on March.1, 2 Many clinical manifestations of this virus are described, and new symptoms are emerging particularly outside respiratory sphere, such as anosmia and ageusia3 which…